• JNK-IN-7 for State-Resolved Apoptosis Assays

  2026-08-25

  JNK-IN-7 enables selective JNK inhibition while preserving a pathway-resolved view of infection-associated apoptosis. This article translates Candida krusei findings into practical assay decisions, including c-Jun phosphorylation, mitochondrial, death-receptor, and innate immune readouts.

• JNK-IN-7: From JNK Mechanism to Translational Insight

  2026-08-25

  A thought-leadership analysis of how JNK-IN-7 can connect covalent kinase biology with infection-associated apoptosis, innate immune signaling, and translational assay design.

• Entinostat (MS-275) for HDAC Research Workflows

  2026-08-24

  Entinostat, also known as MS-275 or SNDX-275, provides a selective class I HDAC platform for connecting histone-acetylation measurements with cancer-cell phenotypes. This guide translates evidence from oncology and axolotl regeneration research into practical assay design, controls, and troubleshooting strategies.

• Toremifene: A Mechanism-First Assay Strategy

  2026-08-24

  Toremifene enables a mechanism-first approach to prostate cancer research by separating estrogen receptor effects from STIM1-dependent calcium and metastatic phenotypes. This article translates recent TSPAN18–STIM1 findings into practical, better-controlled assay decisions.

• CCCP: A Mitochondrial Gradient Stress Test

  2026-08-23

  CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is more than an oxidative phosphorylation uncoupler: it is a controlled perturbation for connecting mitochondrial energetics with live-cell morphology. This article explains how to use and interpret CCCP in morphology-focused biomarker workflows, including urine-derived stem cell research.

• SB203580 in Infection-Driven Lung Inflammation

  2026-08-22

  SB203580 provides a focused way to interrogate p38 MAPK signaling in inflammation linking periodontal infection with COPD-like lung injury. This article translates recent mechanistic findings into practical assay design, pathway readouts, and interpretation safeguards.

• Bedaquiline: From ATP Depletion to Assay Design

  2026-08-21

  Bedaquiline is a diarylquinoline antibiotic whose ATP-synthase mechanism creates distinct experimental signatures in tuberculosis and cancer metabolism models. This guide connects direct bacterial killing with host-directed research and translates the evidence into better assay design.

• ORAI2 Drives Early Postirradiation Salivary Fibrosis

  2026-08-20

  The reference study identifies ORAI2-mediated store-operated calcium entry as an upstream regulator of early postirradiation salivary gland fibrosis and defines an ORAI2/JNK/NFAT1/TGF-β1 signaling axis. Its combined human-cell, mouse, transcriptomic, pharmacological, and functional evidence supports SOCE pathway inhibition as a mechanistic strategy for studying radiation-induced hyposalivation, while leaving clinical translation and long-term safety unresolved.

• Multiomics Maps Acute Liver Injury Drug Responses

  2026-08-20

  This Scientific Reports study used co-expression modules, transcriptomics, and proteomics to compare how bifendate and muaddil sapra act in CCl4-induced acute liver injury. Its main contribution is a systems-level framework that links treatment-associated molecular changes with candidate transcriptional, noncoding RNA, and protein regulators rather than relying on isolated biomarkers.

• Antimycin A4: A Two-Axis Assay Strategy

  2026-08-19

  Antimycin A4 is both an ATP-citrate lyase inhibitor and a mitochondrial respiratory chain inhibitor, creating powerful but easily conflated metabolic phenotypes. This article presents a causal assay framework that separates lipid-biosynthesis effects from respiratory-chain blockade and translates the original Streptomyces findings into better experimental decisions.

• SGC-CBP30 in CREBBP/EP300 Bromodomain Research

  2026-08-19

  Use SGC-CBP30 as a selective mechanistic probe for CREBBP/EP300-dependent transcription, from chromatin occupancy and FRAP assays to TGF-β/SMAD3-driven lung adenocarcinoma models. Its biochemical potency and cellular activity support focused epigenetics research while preserving the need for dose, vehicle, and pathway controls.

• Diclofenac in Intestinal Organoid Research

  2026-08-18

  Use Diclofenac as a mechanistic COX perturbation tool while human iPSC-derived intestinal organoids add clinically relevant metabolism, transport, and epithelial-barrier context. This workflow connects cyclooxygenase inhibition assay design with pharmacokinetic profiling and inflammation signaling pathway analysis.

• Boc-D-FMK: From Caspase Blockade to Translation

  2026-08-18

  Boc-D-FMK is more than a broad-spectrum apoptosis probe: it can help translational researchers separate caspase-dependent cell death from inflammatory and fibrotic phenotypes. This article examines its mechanistic value, assay strategy, model selection, limitations, and opportunities for stronger causal evidence.

• ORAI2 Drives Early Postirradiation Salivary Fibrosis

  2026-08-17

  The reference study identifies ORAI2-mediated store-operated calcium entry as an early driver of radiation-induced salivary gland fibrosis and defines an ORAI2/JNK/NFAT1/TGF-β1 signaling axis. Its results connect calcium influx to fibrotic remodeling and suggest that pathway-level inhibition may help preserve salivary function, while also highlighting the limits of translating pharmacologic findings directly to patients.

• InstaBlue Protein Stain Solution: Practical Gel Guide

  2026-08-17

  InstaBlue Protein Stain Solution provides rapid Coomassie-based visualization of protein bands in polyacrylamide gels without fixation, washing, or destaining. It is suited to routine protein electrophoresis analysis and mass spectrometry workflows, but it should not replace a validated quantitative assay or protocols that require fixed gels or non-Coomassie chemistries.

8586 records 1/573 page Next 12345 下5页 Last page